---
title: "輝瑞公司表示，Braftovi 和 Mektovi 聯合用藥在晚期肺癌患者中展現了持續的長期生存效果"
description: "輝瑞表示，Braftovi + Mektovi 在晚期肺癌患者中顯示出持續的長期生存率"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261745647.md"
published_at: "2025-10-19T06:35:34.000Z"
---

# 輝瑞公司表示，Braftovi 和 Mektovi 聯合用藥在晚期肺癌患者中展現了持續的長期生存效果

> 輝瑞表示，Braftovi + Mektovi 在晚期肺癌患者中顯示出持續的長期生存率

### Related Stocks

- [PFE.US - 輝瑞](https://longbridge.com/zh-HK/quote/PFE.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| This 6.75%-Yielding Dividend Stock Can Gain 33% | Pfizer (NYSE:PFE) shares surged nearly 7% following a pricing deal with the Trump administration, marking a significant  | [Link](https://longbridge.com/zh-HK/news/259690001.md) |
| TrumpRx Brings Pfizer Into the Green—Is It a Buy? | Pfizer has entered a significant agreement with the U.S. government to lower drug costs, which has positively impacted i | [Link](https://longbridge.com/zh-HK/news/260151683.md) |
| Short Interest in Schneider Electric SE (OTCMKTS:SBGSY) Drops By 16.8% | Schneider Electric SE (OTCMKTS:SBGSY) experienced a 16.8% decrease in short interest in January, with 197,858 shares sho | [Link](https://longbridge.com/zh-HK/news/276071356.md) |
| Volkswagen Mulls 20% Company-wide Cost Reduction by 2028-End | Volkswagen Mulls 20% Company-wide Cost Reduction by 2028-End | [Link](https://longbridge.com/zh-HK/news/276044410.md) |
| What to Expect from Palo Alto Networks's Earnings | Palo Alto Networks (NASDAQ:PANW) is set to release its quarterly earnings report on February 17, 2026, with analysts exp | [Link](https://longbridge.com/zh-HK/news/276061399.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
